↓ Skip to main content

What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association

Overview of attention for article published in BMC Clinical Pharmacology, October 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
75 Mendeley
citeulike
1 CiteULike
Title
What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association
Published in
BMC Clinical Pharmacology, October 2011
DOI 10.1186/1472-6904-11-16
Pubmed ID
Authors

Andreas Vilhelmsson, Tommy Svensson, Anna Meeuwisse, Anders Carlsten

Abstract

According to the World Health Organization (WHO) the cost of adverse drug reactions (ADRs) in the general population is high and under-reporting by health professionals is a well-recognized problem. Another way to increase ADR reporting is to let the consumers themselves report directly to the authorities. In Sweden it is mandatory for prescribers to report serious ADRs to the Medical Products Agency (MPA), but there are no such regulations for consumers. The non-profit and independent organization Consumer Association for Medicines and Health, KILEN has launched the possibility for consumers to report their perceptions and experiences from their use of medicines in order to strengthen consumer rights within the health care sector. This study aimed to analyze these consumer reports.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 3%
Norway 1 1%
Switzerland 1 1%
Canada 1 1%
United States 1 1%
Unknown 69 92%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 21%
Researcher 13 17%
Student > Ph. D. Student 10 13%
Student > Bachelor 5 7%
Student > Postgraduate 4 5%
Other 13 17%
Unknown 14 19%
Readers by discipline Count As %
Medicine and Dentistry 20 27%
Psychology 10 13%
Nursing and Health Professions 4 5%
Computer Science 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 14 19%
Unknown 19 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2011.
All research outputs
#3,160,008
of 22,655,397 outputs
Outputs from BMC Clinical Pharmacology
#16
of 56 outputs
Outputs of similar age
#17,867
of 140,376 outputs
Outputs of similar age from BMC Clinical Pharmacology
#2
of 5 outputs
Altmetric has tracked 22,655,397 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 56 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 140,376 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.